Resources

2 min read

China Reveals Its 2025 Coverage Goals for Publicly Funded Healthcare

In September 2021, China’s National Healthcare Security Administration (NHSA), the government agent in charge of publicly funded healthcare announced its 14th five-year plan (FYP), covering the years 2021 to 2025. Our team in China has identified...

Read More

Dasiglucagon Demonstrates Reduced Costs in the Treatment of Severe Hypoglycemia in a Budget Impact Model

Jordan Hinahara and Thomas Goss, members of our Commercial Strategy and Market Access team, contributed to the budget impact model. The objective was...

Read More

What differentiates us? It’s our people

Hear from Brian Loushine and why our people can create great outcomes.

Read More

2 min read

China Payment Reform: 2020 Update

The pilot of implementing a diagnosis related group (DRG) payment model to inpatient hospital care, a major initiative of China’s ongoing healthcare...

Read More

1 min read

China Aims to Complete Transition to DRG Payment Model for Inpatient Care by 2024

In November 2021, the Chinese government announced its 3-year (2022-2024) payment reform plan with the end goal to fully implement a diagnosis...

Read More

2 min read

Key Insights from NMPA Guidance Draft 01 & 02 from Our Human Factors Team

The human factors team at Veranex has reviewed the NMPA Guidance Draft 01 and Draft 02 and submitted feedback to the agency. We’re committed to...

Read More

2 min read

Selling the Science Is a Must to Secure Research Funding

If you cannot sell the science, it is like it was not discovered (#provocativeoverstatement) “Gut science” became a thing during the last decade. I...

Read More

5 min read

Nanomaterials in Medical Devices: Biological Risks and Methodology for Biocompatibility Assessment

Introduction Nanomaterials, tiny scientific wonders that are invisible to the naked eye, hold the potential to revolutionize numerous facets of our...

Read More